Loading the company…
Loading the company…
Families: Hernia repair, Breast biopsy & localization, Cholecystectomy & appendectomy.
All companies · Product and company coverage
The same products and surgeons under a new company (ZimVie): expect new reps and contracts, and ask what changed for them.
Zimmer Biomet press release · closing date to confirm
Paragon 28's surgeons now deal with Zimmer Biomet. Integration brings new reps, contracts and bundles: for a competitor, a window while it settles; for Zimmer Biomet, surgeons to keep.
Payments and FDA records read by the company that owns the business today, so a deal never looks like surgeons switching; a surgeon’s payment history still shows the name each payment was made under.
In the last ten years FDA made 183 decisions for Zimmer Biomet (510(k) clearances, De Novo grants, PMA approvals and supplements) under the product codes MedaRep maps to 3 procedure families, the most in 2019 (32). The latest was on 2026-10-07.
| Family | Decisions on record |
|---|---|
| Hernia repair | 1 |
| Breast biopsy & localization | 1 |
| Cholecystectomy & appendectomy | 1 |
| Date | Kind | Number | Device |
|---|---|---|---|
| 2026-10-07 | 510(k) | K261120 | APEX 3D S Diamond Tibia |
| 2026-09-23 | 510(k) | K261453 | G7® Acetabular System |
| 2026-08-28 | 510(k) | K262722 | Primal K-Wire (P99-193-1410) |
| 2026-08-24 | 510(k) | K253515 | Zimmer Biomet OSS Orthopedic Salvage System OsseoTi® Sleeves and Augments |
| 2026-08-06 | 510(k) | K261121 | Megalodon Dynamic Compression System |
Decisions under the product codes mapped to the procedure families; devices filed under other codes are not here. Applicants are rolled up to Zimmer Biomet.
In 2025, Zimmer Biomet reported engagement with 8,767 surgeons and other clinicians in the states MedaRep covers, worth $13M in consulting, speaking, meals and travel for its device products, the most in California ($1.4M to 826). Royalties are left out.
Spend tied to a procedure counts the payments whose product names it. Open Payments shows the payments companies reported. It suggests engagement, not which devices a surgeon uses, and is not evidence of wrongdoing.Top states by spend: California ($1.4M, 826 engaged), Florida ($1.2M, 637 engaged), New York ($1.1M, 568 engaged), New Jersey ($959K, 336 engaged), Pennsylvania ($920K, 435 engaged).